Vishal Thapar

7.2k total citations · 3 hit papers
23 papers, 4.2k citations indexed

About

Vishal Thapar is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Vishal Thapar has authored 23 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Vishal Thapar's work include Cancer Cells and Metastasis (4 papers), Cancer Genomics and Diagnostics (4 papers) and Algorithms and Data Compression (4 papers). Vishal Thapar is often cited by papers focused on Cancer Cells and Metastasis (4 papers), Cancer Genomics and Diagnostics (4 papers) and Algorithms and Data Compression (4 papers). Vishal Thapar collaborates with scholars based in United States, Austria and India. Vishal Thapar's co-authors include Nicolas Wyvekens, Cyd Khayter, Martin J. Aryee, Shengdar Q. Tsai, J. Keith Joung, Zongli Zheng, Matthew Liebers, A. John Iafrate, Long P. Le and Ved V. Topkar and has published in prestigious journals such as Cell, Journal of the American Chemical Society and Nature Communications.

In The Last Decade

Vishal Thapar

23 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases

2014 1.6k citations Shengdar Q. Tsai, Zongli Zheng et al. Nature Biotechnology profile →
Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing

2014 749 citations Shengdar Q. Tsai, Nicolas Wyvekens et al. Nature Biotechnology profile →
Non-Cell-Autonomous Tumor Suppression by p53

2013 615 citations Amaia Lujambio, Leila Akkari et al. Cell profile →

Peers

Countries citing papers authored by Vishal Thapar

Since Specialization

Citations

This map shows the geographic impact of Vishal Thapar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vishal Thapar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vishal Thapar more than expected).

Fields of papers citing papers by Vishal Thapar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vishal Thapar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vishal Thapar. The network helps show where Vishal Thapar may publish in the future.

Co-authorship network of co-authors of Vishal Thapar

This figure shows the co-authorship network connecting the top 25 collaborators of Vishal Thapar. A scholar is included among the top collaborators of Vishal Thapar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vishal Thapar. Vishal Thapar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Engineered nanointerfaces for microfluidic isolation and molecular profiling of tumor-specific extracellular vesicles 2018 ·Nature Communications ·Eduardo Reátegui, Kristan E. van der Vos, Charles Pin‐Kuang Lai, (unknown), Nadia A. Atai, Berent Aldikacti, (unknown), Aimal H. Khankhel, Vishal Thapar, Fred H. Hochberg, Lecia V. Sequist, Brian V. Nahed, Bob S. Carter, Mehmet Toner, Leonora Balaj, David T. Ting, Xandra O. Breakefield, Shannon L. Stott	258
2	Enhanced Isolation and Release of Circulating Tumor Cells Using Nanoparticle Binding and Ligand Exchange in a Microfluidic Chip 2017 ·Journal of the American Chemical Society ·Myoung‐Hwan Park, Eduardo Reátegui, Wei Li, Shannon N. Tessier, Keith H.K. Wong, Anne Eeg Jensen, Vishal Thapar, David T. Ting, Mehmet Toner, Shannon L. Stott, Paula T. Hammond	242
3	Prediction of potent shRNAs with a sequential classification algorithm 2017 ·Nature Biotechnology ·Raphael Pelossof, Lauren Fairchild, Chun‐Hao Huang, Christian Widmer, Vipin T. Sreedharan, (unknown), (unknown), (unknown), Prem K. Premsrirut, Darjus F. Tschaharganeh, Thomas Hoffmann, Vishal Thapar, Qing Xiang, Ralph Garippa, Gunnar Rätsch, Johannes Zuber, Scott W. Lowe, Christina S. Leslie, Christof Fellmann	96
4	Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 2017 ·Nature Communications ·Keith H.K. Wong, Shannon N. Tessier, David T. Miyamoto, Kathleen L. Miller, (unknown), (unknown), (unknown), Vishal Thapar, Eric C. Tai, Kevin D. Vo, Erin Emmons, (unknown), Rebecca D. Sandlin, Lecia V. Sequist, David T. Ting, Daniel A. Haber, Shyamala Maheswaran, Shannon L. Stott, Mehmet Toner	54
5	BRD4 Connects Enhancer Remodeling to Senescence Immune Surveillance 2016 ·Cancer Discovery ·Nilgun Tasdemir, Ana Banito, Jae‐Seok Roe, Direna Alonso‐Curbelo, Matthew Camiolo, Darjus F. Tschaharganeh, Chun‐Hao Huang, Ozlem Aksoy, Jessica E. Bolden, Chi-Chao Chen, Myles Fennell, Vishal Thapar, Agustin Chicas, Christopher R. Vakoc, Scott W. Lowe	278
6	A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinoma 2016 ·Biomaterials ·(unknown), Matteo Ligorio, David T. Ting, Kristina Xega, Abraham R. Tzafriri, Francesca Bersani, Nicola Aceto, Vishal Thapar, Bryan C. Fuchs, Vikram Deshpande, Aaron B. Baker, Cristina R. Ferrone, Daniel A. Haber, Róbert Langer, Jeffrey W. Clark, Elazer R. Edelman	35
7	The Functional Human C-Terminome 2016 ·PLoS ONE ·Surbhi Sharma, (unknown), (unknown), (unknown), Steven B. Brooks, (unknown), (unknown), (unknown), (unknown), Sanguthevar Rajasekaran, Vishal Thapar, Sean Williams, Martin R. Schiller	13
8	Development of siRNA Payloads to Target KRAS -Mutant Cancer 2014 ·Cancer Discovery ·Tina L. Yuan, Christof Fellmann, Chih-Shia Lee, (unknown), Vishal Thapar, Liam C. Lee, Dennis Hsu, Danielle Grace, (unknown), Johannes Zuber, Ji Luo, Frank McCormick, Scott W. Lowe	93
9	Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing breakdown → 2014 ·Nature Biotechnology ·Shengdar Q. Tsai, Nicolas Wyvekens, Cyd Khayter, (unknown), Vishal Thapar, Deepak Reyon, Mathew J. Goodwin, Martin J. Aryee, J. Keith Joung	749
10	GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases breakdown → 2014 ·Nature Biotechnology ·Shengdar Q. Tsai, Zongli Zheng, Nathalie T. Nguyen, Matthew Liebers, Ved V. Topkar, Vishal Thapar, Nicolas Wyvekens, Cyd Khayter, A. John Iafrate, Long P. Le, Martin J. Aryee, J. Keith Joung	1582
11	Suppression of EZH2 Accelerates MYC-Driven Lymphomagenesis By Inhibition of Apoptosis 2014 ·Blood ·Iris Appelmann, Claudio Scuoppo, Vishal Thapar, (unknown), Amaia Lujambio, Scott W. Lowe, Agustin Chicas	1
12	Non-Cell-Autonomous Tumor Suppression by p53 breakdown → 2013 ·Cell ·Amaia Lujambio, Leila Akkari, Janelle Simon, Danielle Grace, Darjus F. Tschaharganeh, Jessica E. Bolden, Zhen Zhao, Vishal Thapar, Johanna A. Joyce, Valery Krizhanovsky, Scott W. Lowe	615
13	Abstract C54: Pdgfrb is an essential mediator of p53(mut)-driven metastasis in pancreatic cancer 2013 ·Cancer Research ·Susann Weissmueller, Michael Saborowski, Eusebio Manchado, Vishal Thapar, Scott W. Lowe	1
14	Secondary Structure, a Missing Component of Sequence-Based Minimotif Definitions 2012 ·PLoS ONE ·(unknown), Michael R. Gryk, Mark W. Maciejewski, Vishal Thapar, (unknown), Sanguthevar Rajasekaran, Pedro Romero, Keith Dunker, Shuncheng Li, Tomonori Kaneko, Martin R. Schiller	12
15	Efficient parallel and out of core algorithms for constructing large bi-directed de Bruijn graphs 2010 ·BMC Bioinformatics ·(unknown), Sanguthevar Rajasekaran, Hieu Dinh, Matthew Vaughn, Vishal Thapar	15
16	Efficient sorting algorithms for the cell broadband engine 2008 ·Dolly Sharma, Vishal Thapar, Reda A. Ammar, Sanguthevar Rajasekaran, (unknown)	5
17	Minimotif Miner: a tool for investigating protein function 2006 ·Nature Methods ·Sudha Balla, Vishal Thapar, (unknown), (unknown), (unknown), Chun-Hsi Huang, Sanguthevar Rajasekaran, (unknown), (unknown), William A. Mohler, Mark W. Maciejewski, Michael R. Gryk, (unknown), (unknown), Martin R. Schiller	102
18	Randomized And Parallel Algorithms For Distance Matrix Calculations In Multiple Sequence Alignment 2005 ·Journal of Clinical Monitoring and Computing ·Sanguthevar Rajasekaran, Vishal Thapar, (unknown), Chun-Hsi Huang	4
19	High-Performance Exact Algorithms For Motif Search 2005 ·Journal of Clinical Monitoring and Computing ·Sanguthevar Rajasekaran, Sudha Balla, Chun-Hsi Huang, Vishal Thapar, Michael R. Gryk, Mark W. Maciejewski, Martin R. Schiller	17
20	EXACT ALGORITHMS FOR MOTIF SEARCH 2005 ·S. Rajasekaran, (unknown), Chao Huang, Vishal Thapar, Michael R. Gryk, Mark W. Maciejewski, Martin R. Schiller	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact